Editorial: screening for hepatocellular carcinoma in NAFLD-towards abbreviated MRI alternative in patients with obesity?

Aliment Pharmacol Ther. 2022 May;55(9):1210-1211. doi: 10.1111/apt.16887.

Authors

Fanny Lebossé^{1

2

3}, Cyrielle Caussy^{4

5}

Affiliations

¹ Hepatology Unit, Croix Rousse Hospital, Hospices Civils of Lyon, France.
² INSERM 1052, Cancer Research Center of Lyon, France.
³ Lyon 1 University, France.
⁴ Univ Lyon, CarMen Laboratory, INSERM, INRA, INSA Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, France.
⁵ Hospices Civils de Lyon, Département Endocrinologie, Diabète et Nutrition, Hôpital Lyon Sud, Pierre-Bénite, France.

PMID: 35429036
DOI: 10.1111/apt.16887

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Hepatocellular* / diagnostic imaging
Humans
Liver Neoplasms* / diagnostic imaging
Magnetic Resonance Imaging
Non-alcoholic Fatty Liver Disease* / diagnostic imaging
Obesity / complications